NeolPharma IGF-1 LR3 100MCG

IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3) from Neolpharma is a synthetic analog of the naturally occurring IGF-1 hormone, engineered for enhanced stability and a prolonged half-life (up to 20-30 hours compared to natural IGF-1’s 12-15 hours). This version includes a 13-amino-acid extension at the N-terminus and an arginine substitution at position 3, reducing binding to IGF-binding proteins and allowing greater bioavailability. The Neolpharma product comes in a 100 mcg vial, designed for precise dosing. It is primarily researched for its role in promoting cellular proliferation, tissue repair, and metabolic regulation, often in contexts like muscle hypertrophy and recovery.

Benefits

IGF-1 LR3 mimics the effects of growth hormone by stimulating protein synthesis and nitrogen retention, leading to several key advantages, particularly for athletes, bodybuilders, and those focused on anti-aging or performance optimization:

Muscle Hypertrophy and Strength: Promotes hyperplasia (new muscle cell formation) and hypertrophy, increasing lean mass without excessive water retention.

Enhanced Recovery: Accelerates tissue repair post-exercise, reducing soreness and downtime by up to 50% in studies on cellular regeneration.

Fat Loss and Metabolism Boost: Improves lipolysis (fat breakdown) and glucose uptake, aiding body recomposition and potentially increasing metabolic rate by 10-20%.

Performance Enhancement: Boosts endurance, stamina, and overall energy levels, with some users reporting improved libido and cognitive function.

Usage Instructions

IGF-1 LR3 is typically administered via subcutaneous injection for optimal absorption. Always consult a healthcare professional before use, as it is often intended for research purposes only.

• Dosage: Beginners: 20-40 mcg/day; Advanced: 50-100 mcg/day. Split doses if exceeding 50 mcg (e.g., morning and post-workout).
• Frequency: Once daily, preferably in the morning on an empty stomach or immediately post-workout with a meal to counteract potential hypoglycemia.
• Cycle Length: 4-6 weeks on, followed by 4 weeks off to prevent desensitization. Do not exceed 8 weeks continuously.
• Reconstitution: Add bacteriostatic water to the 100 mcg vial (e.g., 1-2 mL for 50-100 mcg/mL concentration). Store reconstituted vial in the refrigerator (2-8°C); do not freeze.
• Administration Tips: Use insulin syringes for precision. Rotate injection sites (abdomen, thighs) to avoid irritation. Pair with a high-protein diet and resistance training for best results.

Cautions

IGF-1 LR3 is not FDA-approved for human therapeutic use and is primarily for laboratory research. Potential risks include:

• Hypoglycemia: Monitor blood sugar, as it can mimic insulin effects—symptoms include dizziness or fatigue.
• Side Effects: Water retention, joint pain, or headaches; rare but serious risks like increased cancer cell proliferation due to growth promotion.
• Contraindications: Avoid if pregnant, breastfeeding, or with history of cancer, diabetes, or heart issues. Not for those under 18.
• Storage and Handling: Keep away from children; discard if seal is broken. Use under medical supervision to mitigate interactions with other hormones or medications.